Novavax Inks $250M Stock Sales Deal

5/18/20

By Douglas W. House, SA

COVID-19 vaccine developer Novavax (NASDAQ:NVAX) enters into an agreement with B. Riley FBR for the at-the-market sale of up the $250M of its common stock.

The agent will earn a 2% commission for its efforts.

Shares down 1% after hours.

READ FULL ARTICLE HERE

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.

Connect with these Baltimore Professionals on LinkedIn

  • Edwin Warfield

    Editor in Chief, Warfield Digital

    Connect

  • Jean Halle

    Independent Consultant

    Connect

  • Larry Lichtenauer

    President of Lawrence Howard & Associates

    Connect

  • Newt Fowler

    Partner at Womble Carlyle, LLP

    Connect

  • David Crowley

    Owner at Develop DC

    Connect

  • Carolyn Stinson

    Stinson Marketing Group

    Connect
Feature Your Profile Here